News
MIST
1.150
+10.58%
0.110
Weekly Report: what happened at MIST last week (0720-0724)?
Weekly Report · 3d ago
Analysts’ Top Healthcare Picks: AgomAb Therapeutics NV ADR (AGMB), Milestone Pharmaceuticals (MIST)
TipRanks · 07/23 08:00
Weekly Report: what happened at MIST last week (0713-0717)?
Weekly Report · 07/20 09:12
Weekly Report: what happened at MIST last week (0706-0710)?
Weekly Report · 07/13 09:12
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 07/07 21:05
Weekly Report: what happened at MIST last week (0629-0703)?
Weekly Report · 07/06 09:13
Milestone Pharma grants 288,000 inducement stock options at $1.32/share
PUBT · 07/03 01:33
Milestone Pharmaceuticals grants 288,000 inducement stock options at $1.32 per share
PUBT · 07/03 01:30
MILESTONE PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 07/03 01:30
Weekly Report: what happened at MIST last week (0622-0626)?
Weekly Report · 06/29 09:12
Alpha Cognition elects Robert Wills as board chairman
PUBT · 06/23 12:30
Weekly Report: what happened at MIST last week (0615-0619)?
Weekly Report · 06/22 09:14
Milestone Pharmaceuticals Shareholders Approve Governance and Compensation Measures
TipRanks · 06/15 21:00
Milestone Pharmaceuticals shareholders approve 6.8 million-share increase to 2019 equity plan
PUBT · 06/15 20:06
Weekly Report: what happened at MIST last week (0608-0612)?
Weekly Report · 06/15 09:13
Milestone Pharmaceuticals: Here Comes The Revenue Ramp
Seeking Alpha · 06/09 19:38
Weekly Report: what happened at MIST last week (0601-0605)?
Weekly Report · 06/08 09:13
Milestone Pharmaceuticals: Taking The Long View
Seeking Alpha · 06/03 12:25
Milestone (MIST) Q1 2026 Earnings Transcript
The Motley Fool · 06/01 14:31
Weekly Report: what happened at MIST last week (0525-0529)?
Weekly Report · 06/01 09:14
More
Webull provides a variety of real-time MIST stock news. You can receive the latest news about Milestone Pharmaceuticals through multiple platforms. This information may help you make smarter investment decisions.
About MIST
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.